-
1.发明授权Tests to predict responsiveness of cancer patients to chemotherapy treatment options 有权预测癌症患者对化疗治疗选择的反应性的测试
公开(公告)号：EP2607497B1
公开(公告)日：2014-10-01
申请号：EP13159677.7
申请日：2009-05-12
发明人： Shak, Steve , Baker, Joffre , Yoshizawa, Carl , Gray, Robert , Sparano, Joseph
IPC分类号： C12Q1/68 , G01N33/53 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/574 , G01N33/57415 , G01N2333/705 , G01N2333/72 , G01N2800/52 , G01N2800/60
-
2.发明授权Tests to predict responsiveness of cancer patients to chemotherapy treatment options 有权测试预测癌症患者的化疗治疗方案的响应
公开(公告)号：EP2641977B1
公开(公告)日：2014-09-03
申请号：EP13172854.5
申请日：2009-05-12
发明人： Shak, Steve , Baker, Joffre , Yoshizawa, Carl , Sparano, Joseph , Gray, Robert
IPC分类号： C12Q1/68 , G01N33/53 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/574 , G01N33/57415 , G01N2333/705 , G01N2333/72 , G01N2800/52 , G01N2800/60
-
3.发明授权Tests to predict responsiveness of cancer patients to chemotherapy treatment options 有权测试预测癌症患者的化疗治疗方案的响应
公开(公告)号：EP2568053B1
公开(公告)日：2014-04-16
申请号：EP12195318.6
申请日：2009-05-12
申请人： Genomic Health, Inc. , Aventis Inc.
发明人： Shak, Steve , Baker, Joffre , Yoshizawa, Carl , Sparano, Joseph , Gray, Robert
IPC分类号： C12Q1/68 , G01N33/53 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/574 , G01N33/57415 , G01N2333/705 , G01N2333/72 , G01N2800/52 , G01N2800/60
-
公开(公告)号：EP2641978A1
公开(公告)日：2013-09-25
申请号：EP13172903.0
申请日：2009-05-12
申请人： Genomic Health, Inc. , Aventis Inc.
发明人： Shak, Steve , Baker, Joffre , Yoshizawa, Carl , Sparano, Joseph , Gray, Robert
IPC分类号： C12Q1/68 , G01N33/53 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/574 , G01N33/57415 , G01N2333/705 , G01N2333/72 , G01N2800/52 , G01N2800/60
摘要： The present disclosure provides methods and compositions to facilitate prediction of the likelihood of responsiveness of cancer patients to treatment including a taxane and/or a cyclophosphamide.
-
公开(公告)号：EP2607497A1
公开(公告)日：2013-06-26
申请号：EP13159677.7
申请日：2009-05-12
申请人： Genomic Health, Inc. , Aventis Inc.
发明人： Shak, Steve , Baker, Joffre , Yoshizawa, Carl , Gray, Robert , Sparano, Joseph
IPC分类号： C12Q1/68 , G01N33/53 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/574 , G01N33/57415 , G01N2333/705 , G01N2333/72 , G01N2800/52 , G01N2800/60
摘要： The present disclosure provides methods and compositions to facilitate prediction of the likelihood of responsiveness of cancer patients to treatment including a taxane and/or a cyclophosphamide.
-
6.发明公开Tests to predict responsiveness of cancer patients to chemotherapy treatment options 有权测试zur Vorhersage derReaktionsfähigkeitvon Krebspatienten auf Chemotherapiebehandlungsoptionen
公开(公告)号：EP2568053A1
公开(公告)日：2013-03-13
申请号：EP12195318.6
申请日：2009-05-12
申请人： Genomic Health, Inc. , Aventis Inc.
发明人： Shak, Steve , Baker, Joffre , Yoshizawa, Carl , Sparano, Joseph , Gray, Robert
IPC分类号： C12Q1/68 , G01N33/53 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/574 , G01N33/57415 , G01N2333/705 , G01N2333/72 , G01N2800/52 , G01N2800/60
摘要： The present disclosure provides methods and compositions to facilitate prediction of the likelihood of responsiveness of cancer patients to treatment including a taxane and/or a cyclophosphamide.
摘要翻译： 本公开提供了有助于预测癌症患者对治疗包括紫杉烷和/或环磷酰胺的治疗的可能性的方法和组合物。
-
7.发明公开Tests to predict responsiveness of cancer patients to chemotherapy treatment options 有权预测癌症患者对化疗治疗选择的反应性的测试
公开(公告)号：EP2641977A1
公开(公告)日：2013-09-25
申请号：EP13172854.5
申请日：2009-05-12
申请人： Genomic Health, Inc. , Aventis Inc.
发明人： Shak, Steve , Baker, Joffre , Yoshizawa, Carl , Sparano, Joseph , Gray, Robert
IPC分类号： C12Q1/68 , G01N33/53 , G01N33/574
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N33/574 , G01N33/57415 , G01N2333/705 , G01N2333/72 , G01N2800/52 , G01N2800/60
摘要： The present disclosure provides methods and compositions to facilitate prediction of the likelihood of responsiveness of cancer patients to treatment including a taxane and/or a cyclophosphamide.
摘要翻译： 本公开提供了方法和组合物以促进预测癌症患者对包括紫杉烷和/或环磷酰胺的治疗的响应性的可能性。
-
8.发明公开Gene expression markers of recurrence risk in cancer patients after chemotherapy 审中-公开Genexpressionsmarker des Wiederholungsrisikos bei Krebspatienten nach der Chemotherapie
公开(公告)号：EP2228457A1
公开(公告)日：2010-09-15
申请号：EP10161883.3
申请日：2008-08-15
申请人： Genomic Health, Inc. , Aventis Inc.
发明人： Shak, Steven , Baker, Joffre , Yoshizawa, Carl , Sparano, Joseph , Gray, Robert
IPC分类号： C12Q1/68
CPC分类号： C12Q1/6886 , C12Q2600/106 , C12Q2600/118 , C12Q2600/156
摘要： The present invention relates to genes, the expression levels of which are correlated with likelihood of breast cancer recurrence in patients after tumor resection and chemotherapy.
摘要翻译： 本发明涉及在肿瘤切除和化疗后患者的乳腺癌复发可能性与其表达水平相关的基因。
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.016 秒)
